13 results
424B3
MRZM
Marizyme, Inc.
16 Nov 23
Prospectus supplement
6:08am
for procedures such as plastic and cosmetic surgery.
In the near term, we expect to generate revenue primarily from the sale of DuraGraft through
424B3
MRZM
Marizyme, Inc.
17 Oct 23
Prospectus supplement
5:10pm
to fully develop and market MAR-FG-001 in the U.S. for fat grafting for procedures such as plastic and cosmetic surgery.
In the near term, we expect … grafting technology. MAR-FG-001 is a tumescent solution base for fat grafting procedures that may be used for plastic and cosmetic surgeries
- Prev
- 1
- Next